about
Resveratrol as a natural anti-tumor necrosis factor-α molecule: implications to dendritic cells and their crosstalk with mesenchymal stromal cellsSystemic Delivery of Bone Marrow Mesenchymal Stem Cells for In Situ Intervertebral Disc RegenerationMatrix metalloproteases as maestros for the dual role of LPS- and IL-10-stimulated macrophages in cancer cell behaviour.The two faces of metal ions: From implants rejection to tissue repair/regeneration.Open conformers: the hidden face of MHC-I molecules.miR-195 in human primary mesenchymal stromal/stem cells regulates proliferation, osteogenesis and paracrine effect on angiogenesis.Cross talk between the Akt and p38α pathways in macrophages downstream of Toll-like receptor signaling.Injectable MMP-sensitive alginate hydrogels as hMSC delivery systems.Circulating extracellular vesicles: Their role in tissue repair and regeneration.Extracellular Vesicles: Immunomodulatory messengers in the context of tissue repair/regeneration.Adsorbed Fibrinogen stimulates TLR-4 on monocytes and induces BMP-2 expression.Fibrinogen scaffolds with immunomodulatory properties promote in vivo bone regeneration.Endoplasmic reticulum degradation-enhancing α-mannosidase-like protein 1 targets misfolded HLA-B27 dimers for endoplasmic reticulum-associated degradation.Novel detection of in vivo HLA-B27 conformations correlates with ankylosing spondylitis association.Induction of HLA-B27 heavy chain homodimer formation after activation in dendritic cellsMajor histocompatibility complex class I-ERp57-tapasin interactions within the peptide-loading complex.Bridging Autism Spectrum Disorders and Schizophrenia through inflammation and biomarkers - pre-clinical and clinical investigations.Nanostructured lipid carriers loaded with resveratrol modulate human dendritic cells.Adsorbed fibrinogen leads to improved bone regeneration and correlates with differences in the systemic immune response.Misfolding of major histocompatibility complex class I molecules in activated T cells allows cis-interactions with receptors and signaling molecules and is associated with tyrosine phosphorylation.Novel MHC class I structures on exosomes.The kinases MSK1 and MSK2 act as negative regulators of Toll-like receptor signaling.miR-195 inhibits macrophages pro-inflammatory profile and impacts the crosstalk with smooth muscle cells.Targeted macrophages delivery of rifampicin-loaded lipid nanoparticles to improve tuberculosis treatment.The use of chitosan porous 3D scaffolds embedded with resolvin D1 to improve in vivo bone healing.Pro-inflammatory chitosan/poly(γ-glutamic acid) nanoparticles modulate human antigen-presenting cells phenotype and revert their pro-invasive capacity.Integrated Analysis of Biological Samples by Imaging Flow CytometryProfiling the circulating miRnome reveals a temporal regulation of the bone injury responseMesenchymal Stromal Cell Secretome: Influencing Therapeutic Potential by Cellular Pre-conditioningExtracellular vesicles: intelligent delivery strategies for therapeutic applicationsFibrinogen promotes resorption of chitosan by human osteoclastsBiochemical Features of HLA-B27 and Antigen ProcessingERp57 interacts with conserved cysteine residues in the MHC class I peptide-binding grooveLong noncoding RNAs: a missing link in osteoporosisPeripheral Biomarkers for First-Episode Psychosis-Opportunities from the Neuroinflammatory Hypothesis of SchizophreniaModulation of the In Vivo Inflammatory Response by Pro- Versus Anti-Inflammatory Intervertebral Disc TreatmentsThe Systemic Immune Response to Collagen-Induced Arthritis and the Impact of Bone Injury in Inflammatory ConditionsOsteoclasts degrade fibrinogen scaffolds and induce mesenchymal stem/stromal osteogenic differentiationMacrophages Down-Regulate Gene Expression of Intervertebral Disc Degenerative Markers Under a Pro-inflammatory MicroenvironmentGenetically Engineered-MSC Therapies for Non-unions, Delayed Unions and Critical-size Bone Defects
P50
Q28540693-96A4E96F-BB8D-4BBB-9576-E39AF12030E2Q33722380-9AFA8942-5194-47B5-9F6E-9230CBE109D9Q35653181-0E18901F-59F5-4F1D-A9E1-11F900D05FE4Q35916452-9FD6FBF8-DBD3-4BB2-A7CE-A8D310A2CD34Q36721442-C7B85E25-56F5-4931-BB1B-D1E4BDA4CCD9Q36729331-78655FE8-C0EE-40CD-B136-C4465BDE2D78Q37265027-99EFEB9A-2B9C-46F7-9FDE-0E943E57E12DQ37569930-71E324A9-2EC4-4983-97A8-43298121DD33Q38836585-F1E86D86-F542-4EB6-AE7E-80BA7001029AQ38958697-619F4C86-BFD0-48B5-8648-E4FB950738EDQ39179960-5005DC2B-8994-442A-89F0-6BC1194A7F0CQ39302383-6997C1A1-F723-4C0B-8E7F-9AAC60DDDB57Q39703354-D563BEA0-ACC2-4D0E-8F09-373FC277D569Q39922842-3967CD94-D94E-4535-BC26-028E0D88B288Q39945166-8AE481C2-68F5-4AD8-9AD8-1754B52486FFQ40140969-96C05055-8D56-4AFE-A473-55994D74F9A2Q41611297-84AFF6E2-F6D7-4181-A060-47577C5F49CBQ42386406-BC6BEE0C-FEB5-4B28-B417-1CE291F4D5D8Q44713232-7E8A09B8-247D-4291-9C33-FC51ECA98435Q45096225-815E996A-B813-46F3-87EA-B7954374657BQ45930114-14D52809-9D68-45B9-9E9D-12B50A2B023DQ46438489-573B3481-1015-4ACB-9753-33714313B221Q47093765-5E6C548B-F990-4E38-9813-323FC2C3AE5CQ48606369-AF3ADB22-A388-4042-845C-83C61C380F22Q49907151-866AD525-4B34-47F3-AAFB-3DA057028772Q50052617-EEDAB789-6598-4F16-BDDB-EC41BBD54298Q57556353-8083A788-ED8E-49CB-9C91-AEFBFB56F49EQ59123165-69E537AB-8C36-4B9F-9A3B-DBB01C3CEB75Q60046871-654C7BD0-20FF-480B-A717-E2E824104B51Q60199289-84E985CF-AC67-4530-A759-9F1DE48B13C1Q60199310-E91D7757-39EF-483D-9235-20732C1BF57BQ60199314-3867C450-1F1D-406C-A6DB-B33DCB5D3DD3Q60199322-94B3FDD0-D7B7-43C5-BDC4-95EDCE9D6120Q64110684-49C3CDAA-8DFB-4CB5-8DBE-991A22EB169AQ64123533-C9307ABA-F398-4BFC-BBD0-D5647C144F46Q90074709-75399E35-0F81-42F9-8614-C7C92C038470Q91094413-9A58045F-63C9-4071-BA73-2CC66DAD702CQ92036229-3A6078AE-6391-44B7-8EA7-17573BA0B906Q92106819-E4F468F2-5859-4D17-B8E6-453E5023806EQ92128783-E0E9E806-12D7-4192-AB78-2221FB4A83B5
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Susana G Santos
@es
Susana G Santos
@nl
Susana G Santos
@sl
Susana G. Santos
@en
type
label
Susana G Santos
@es
Susana G Santos
@nl
Susana G Santos
@sl
Susana G. Santos
@en
altLabel
Gomes S.
@en
Santos S.
@en
prefLabel
Susana G Santos
@es
Susana G Santos
@nl
Susana G Santos
@sl
Susana G. Santos
@en
P1053
L-9351-2013
P106
P108
P1153
7102756234
P21
P31
P3829
P496
0000-0002-8604-2978